During the past decade, Alvin and Lois Lapidus Cancer Institute at Sinai Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 27 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alvin and Lois Lapidus Cancer Institute at Sinai Hospital" #1 sponsor was "Children's Oncology Group" with 29 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Eximias Pharmaceutical" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alvin and Lois Lapidus Cancer Institute at Sinai Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 53 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Alvin and Lois Lapidus Cancer Institute at Sinai Hospital" are "Breast Cancer" (11 trials), "Leukemia" (11 trials), "Lymphoma" (8 trials), "Sarcoma" (6 trials) and "Neuroblastoma" (5 trials). Many other conditions were trialed in "Alvin and Lois Lapidus Cancer Institute at Sinai Hospital" in a lesser frequency.

Most popular intervention types in "Alvin and Lois Lapidus Cancer Institute at Sinai Hospital" are "Drug" (44 trials), "Biological" (22 trials), "Procedure" (18 trials), "Radiation" (14 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (20 trials), "doxorubicin hydrochloride" (15 trials), "etoposide" (15 trials), "filgrastim" (13 trials) and "radiation therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "Alvin and Lois Lapidus Cancer Institute at Sinai Hospital" are 46 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Alvin and Lois Lapidus Cancer Institute at Sinai Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".